redprince
14 Oct 2019
Provexis Have to agree peppa - there is no guarantee that By-Health will launch anything in China let alone anywhere else. I would suggest that Wheelds is simply clutching at straws.Yes IF By-Health get ordering in large scale then unit costs drop for those formats and that increases likelihood of much bigger players joning the fray. However the point that Wheelds is trying to make is virtually irrelevent at this point.
peppapig
14 Oct 2019
Provexis This is utter tosh Wheelds. A trade deal between US/China will make no difference whasoever to our situation, why are you so hung up on this?
wheelds
12 Oct 2019
Provexis Today on CNN news:- President Trump stated:- “Substantial initial Trade Deal reached with China.â€
wheelds
11 Oct 2019
Provexis Share price up today all based on the expected good deal between the U.S. and China. And as we all know we are waiting to see what the Chinese company By-Health is going to do with our Fruitflow once its tests are confirmed by the Chinese regulator on top of the Chinese government is concerned about the health concerns about the growing Chinese ageing population. Hence, Fruitflow has a massive potential in China where natural health products are the way to stay healthy.
peppapig
11 Oct 2019
Provexis Classic wheelds nonsense, "From the article:- “Lycopene, although prevalent in tomatoes, is not absorbed well when the fruit is eaten, so it would need to be administered as a tablet.†The marvels of Fruitflow. wheelds, so you reckon FF contains Lycopene? Get a grip
Boring_Bernie
11 Oct 2019
Provexis wheelds: Its been over two months now and still no further update:- We might hear something before the Interims are due out in December, but I suspect you’ll have to wait until then for an update
wheelds
11 Oct 2019
Provexis Its been over two months now and still no further update:- 2 August 2019 | 07:51am StockMarketWire.com - Heart-health food ingredient manufacturer Provexis said it had entered into a collaboration agreement with Chinese dietary supplement business By-Health. The arrangement would support the launch of some of Provexis’s Fruitflow-based products in the Chinese market. It had been structured on an open-ended framework basis, enabling the parties to conduct a number of different projects over an unspecified period of time. Project work was expected be managed and conducted by Provexis primarily in the UK, led by chief scientific officer Niamh O’Kennedy and supported by outsourced research partners, which would be appointed and managed by Provexis.
nest_of_rampers
29 Sep 2019
Provexis OT interesting story on the bent FDA Here is a UK site on the bent big pharma practices here mhracorrupt.st Home - mhracorrupt.st The mhra protect the billion dollar monopolies of the big pharmaceuticals & ruthlessly close down inexpensive but effective scientifically proven treatments
wheelds
20 Sep 2019
Provexis peppapig: , he could have waited for the official cash call. Yes ," he could have waited for the official cash call." Hence, in my opinion, he expect good news relative to whats going on in China and share price rises and then the official cash call at a higher share price. IMHO
redprince
17 Sep 2019
Provexis Agree peppa.Not a huge fan of mystic meg myself.She harps on avout her rec of J&J to IF but neglects to mention they are at the very high end of the charging scale in their industry.Still as she does not actually own any shares she prob does not worry about details like that. Aimho.
peppapig
17 Sep 2019
Provexis Good to see mystic Bella plying her trade on the red channel. Once wheelds gets wind of the Chinese military games there will be no stopping him. Although I somehow doubt that a product such as ours will be of much interest to the military, they’ll be on much stronger stuff not widely available I do wonder if the recent Director share purchase was encouraged by the nomad. There is a cash raise coming anytime now, and a show of confidence from the BOD can only help matters. As Bella points out, he could have waited for the official cash call. Cobalt sell your 1000 shares and clear off
Boring_Bernie
13 Sep 2019
Provexis There’s been a bit of talk over the last year or two about this, and I’m currently having a proper look through the report, and note the bit which says “Ian joined the Company as Finance Director in 2007 and he has been very closely involved with the Company’s relationships and contracts with DSM, ByHealth and the Company’s investors over that time. Ian currently divides his working time between the UK and Australia, meeting frequently with DSM in Basel, and with By-Health at their offices in Guangzhou†So, in terms of his residence as documented at Companies House, I’d garner from the above that he spends enough time in the UK to be able to legitimately say that his country of residence is the UK, but, as Farmgal ( Bella ) has previously pointed out, he’s spending a fair amount of time living in Australia I don’t think it’s really that important where he spends most of his time tbh, but I thought I’d share the info anyway BB
Boring_Bernie
12 Sep 2019
Provexis redprince: Just when i was feeling somewhat calmer about our situation we get the clanger of an rns today detailing the eye watering amount of options being granted to the bod. I get, and share to some extent, the angst about this sort of thing, but options are just that, options. At the risk of picking old scabs, I think the only options exercised by a board member belonged to Moon ? Some of Ford et als existing options are, barring a massive re-rating, pretty much worthless, so they’re effectively resetting the baseline every time they issue themselves new options … which is the bit which pisses me off. Anyway, to cut a long story short, if Ford ever exercises and sells a shed load of options, then ignore what anyone sells on bulletin boards, and, at least to some extent,follow his lead BB
redprince
12 Sep 2019
Provexis Just when i was feeling somewhat calmer about our situation we get the clanger of an rns today detailing the eye watering amount of options being granted to the bod.Scant on any detail as to the performance required to achieve them … snouts in the trough once again. Aggregate bod remuneration is up considerably on last year. IF is granted 50 million options at 0.3p subject to some hidden share price performance!! This is simply disgraceful. And they wonder why we have little faith in them. Still they know they can get away with it…
Boring_Bernie
10 Sep 2019
Provexis We’re away at the moment, so I’ve only had a fairly quick skim of the results. On the face if it, unless I’m missing something, everything is pretty much as indicated in the Trading Update and subsequent By-Health RNS, which, given they were fairly recent, is to be expected. I think they’ve been slighty more specific on the timing of the next fund raise this time out ( in the coming six months as opposed to in the coming months ), which I’d take as a slight positive compared to the trading update. BB
